Key result
Hypertensive disorders in pregnancy increase maternal risk for future cardiovascular disease and exhibit disparities in racial prevalence and outcomes.
Why the study?
Hypertensive disorders in pregnancy are a leading cause of maternal and fetal morbidity and mortality, with poorly understood pathophysiology and differing treatment thresholds across organizations.
This review highlights the need for improved management of hypertensive disorders of pregnancy to mitigate future cardiovascular risk and address racial disparities.
Supports closer postpartum CVD surveillance after hypertensive pregnancy disorders; leaves open optimal disparity-reducing interventions.
Hypertensive disorders in pregnancy (HDPs) are a leading cause of maternal and fetal morbidity and mortality worldwide. The pathophysiology is complex and still poorly understood but thought to involve a combination of maternal modifiable and nonmodifiable risk factors and placental changes with resultant end-organ dysfunction. Treatment of HDP involves a combination of lifestyle modification and pharmacotherapy, with differing treatment thresholds across organizations. HDP can increase maternal risk for future cardiovascular disease and has shown disparities in racial prevalence and outcomes. Additional efforts are needed to minimize the risk for future cardiovascular disease and improve racial disparities in patients facing HDP.
No takes yet. Share an insight, caveat, or question.
Ramchandani et al. (2025) conducted a review in Hypertensive disorders in pregnancy. Hypertensive disorders in pregnancy increase maternal risk for future cardiovascular disease and exhibit disparities in racial prevalence and outcomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: